Promotion of activated human B cell apoptosis and inhibition of Ig production by soluble CD95 ligand: CD95-based downregulation of Ig production need not culminate in activated B cell death.
暂无分享,去创建一个
P. Casali | P. Kiener | W. Stohl | G. Starling | D. Xu | Dong Xu | Paolo Casali
[1] C. Bortner,et al. Caspase Independent/Dependent Regulation of K+, Cell Shrinkage, and Mitochondrial Membrane Potential during Lymphocyte Apoptosis* , 1999, The Journal of Biological Chemistry.
[2] T. Sumida,et al. Tumor necrosis factor alpha regulation of the FAS-mediated apoptosis-signaling pathway in synovial cells. , 1999, Arthritis and rheumatism.
[3] P. Kiener,et al. Superantigen-driven, CD8+ T cell-mediated down-regulation: CD95 (Fas)-dependent down-regulation of human Ig responses despite CD95-independent killing of activated B cells. , 1998, Journal of immunology.
[4] C. Brady,et al. The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma. , 1998, Journal of immunology.
[5] T. Whiteside,et al. Lymphocyte apoptosis induced by Fas ligand- expressing ovarian carcinoma cells. Implications for altered expression of T cell receptor in tumor-associated lymphocytes. , 1998, The Journal of clinical investigation.
[6] P. Kiener,et al. CD95 (Fas)-based, superantigen-dependent, CD4+ T cell-mediated down-regulation of human in vitro immunoglobulin responses. , 1998, Journal of immunology.
[7] T. Giese,et al. Spontaneous Development of Plasmacytoid Tumors in Mice with Defective Fas–Fas Ligand Interactions , 1998, The Journal of experimental medicine.
[8] J. Tschopp,et al. Conversion of Membrane-bound Fas(CD95) Ligand to Its Soluble Form Is Associated with Downregulation of Its Proapoptotic Activity and Loss of Liver Toxicity , 1998, The Journal of experimental medicine.
[9] S. Nagata,et al. Downregulation of Fas ligand by shedding , 1998, Nature Medicine.
[10] G. Nolan,et al. Toso, a cell surface, specific regulator of Fas-induced apoptosis in T cells. , 1998, Immunity.
[11] N. Harindranath,et al. CD40 ligand and appropriate cytokines induce switching to IgG, IgA, and IgE and coordinated germinal center and plasmacytoid phenotypic differentiation in a human monoclonal IgM+IgD+ B cell line. , 1998, Journal of immunology.
[12] T. Ochi,et al. Membrane Fas Ligand Kills Human Peripheral Blood T Lymphocytes, and Soluble Fas Ligand Blocks the Killing , 1997, The Journal of experimental medicine.
[13] Y. Goltsev,et al. CASH, a Novel Caspase Homologue with Death Effector Domains* , 1997, The Journal of Biological Chemistry.
[14] S. Srinivasula,et al. FLAME-1, a Novel FADD-like Anti-apoptotic Molecule That Regulates Fas/TNFR1-induced Apoptosis* , 1997, The Journal of Biological Chemistry.
[15] Margot Thome,et al. Inhibition of death receptor signals by cellular FLIP , 1997, Nature.
[16] G. Camussi,et al. Development of Inflammatory Angiogenesis by Local Stimulation of Fas In Vivo , 1997, The Journal of experimental medicine.
[17] K. Isselbacher,et al. Expression of Fas ligand in liver metastases of human colonic adenocarcinomas. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[18] D. Goeddel,et al. Casper is a FADD- and caspase-related inducer of apoptosis. , 1997, Immunity.
[19] Jürgen Bajorath,et al. Identification of Amino Acid Residues Important for Ligand Binding to Fas , 1997, The Journal of experimental medicine.
[20] T. Mosmann,et al. Cytotoxicity and weak CD40 ligand expression of CD8+ type 2 cytotoxic T cells restricts their potential B cell helper activity , 1997, European journal of immunology.
[21] Erwin G. Van Meir,et al. Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain? , 1997, The Journal of clinical investigation.
[22] P. Galle,et al. Lymphocyte apoptosis induced by CD95 (APO–1/Fas) ligand–expressing tumor cells — A mechanism of immune evasion? , 1996, Nature Medicine.
[23] K. Sullivan,et al. Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity. , 1996, The New England journal of medicine.
[24] J. Tschopp,et al. Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape , 1996, Science.
[25] K. Okumura,et al. Fas-mediated stimulation induces IL-8 secretion by rheumatoid arthritis synoviocytes independently of CPP32-mediated apoptosis. , 1996, Biochemical and biophysical research communications.
[26] M. Tanaka,et al. Apoptosis of mouse naive T cells induced by recombinant soluble Fas ligand and activation-induced resistance to Fas ligand. , 1996, Journal of immunology.
[27] A. Hayday,et al. A tumor-suppressor function for Fas (CD95) revealed in T cell-deficient mice , 1996, The Journal of experimental medicine.
[28] P. Schur,et al. Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. , 1996, The Journal of clinical investigation.
[29] G. M. Fischer,et al. Intracellular signaling for inducible antigen receptor-mediated Fas resistance in B cells. , 1996, Journal of immunology.
[30] P. Kiener,et al. Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils , 1996, The Journal of experimental medicine.
[31] Y. S. Choi,et al. Cellular and molecular factors that regulate the differentiation and apoptosis of germinal center B cells. Anti-Ig down-regulates Fas expression of CD40 ligand-stimulated germinal center B cells and inhibits Fas-mediated apoptosis. , 1996, Journal of immunology.
[32] R. Eisenberg,et al. bcl-2 transgenic Lpr mice show profound enhancement of lymphadenopathy. , 1995, Journal of immunology.
[33] D. Green,et al. Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege , 1995, Science.
[34] J. Banchereau,et al. Fas ligation induces apoptosis of CD40-activated human B lymphocytes , 1995, The Journal of experimental medicine.
[35] S. Targan,et al. Divergent induction of apoptosis and IL-8 secretion in HT-29 cells in response to TNF-alpha and ligation of Fas antigen. , 1995, Journal of immunology.
[36] P. Krammer,et al. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway , 1995, The Journal of experimental medicine.
[37] D. Bellgrau,et al. A role for CD95 ligand in preventing graft rejection , 1995, Nature.
[38] S. Fortune,et al. Opposing roles of CD95 (Fas/APO-1) and CD40 in the death and rescue of human low density tonsillar B cells. , 1995, Journal of immunology.
[39] W. Stohl,et al. Differential human T cell-dependent B cell differentiation induced by staphylococcal superantigens (SAg). Regulatory role for SAg-dependent B cell cytolysis. , 1995, Journal of immunology.
[40] Mark M. Davis,et al. CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+T cells , 1995, Nature.
[41] Warren Strober,et al. Dominant interfering fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome , 1995, Cell.
[42] F. Rieux-Laucat,et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. , 1995, Science.
[43] B. Aggarwal,et al. Fas antigen signals proliferation of normal human diploid fibroblast and its mechanism is different from tumor necrosis factor receptor , 1995, FEBS letters.
[44] John Calvin Reed,et al. FAP-1: a protein tyrosine phosphatase that associates with Fas. , 1995, Science.
[45] S. Ju,et al. Protection against Fas-dependent Thl-mediated apoptosis by antigen receptor engagement in B cells , 1995, Nature.
[46] J. Tschopp,et al. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways , 1994, Nature.
[47] P. Linsley,et al. Human T cell-dependent B cell differentiation induced by staphylococcal superantigens. , 1994, Journal of immunology.
[48] P. Krammer,et al. Activation induces sensitivity toward APO-1 (CD95)-mediated apoptosis in human B cells. , 1994, Journal of immunology.
[49] S. Ju,et al. Participation of target Fas protein in apoptosis pathway induced by CD4+ Th1 and CD8+ cytotoxic T cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[50] M R Alderson,et al. The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. , 1994, Immunity.
[51] L. Glimcher,et al. Prevention of nephritis in major histocompatibility complex class II- deficient MRL-lpr mice , 1994, The Journal of experimental medicine.
[52] F. Ramsdell,et al. gld/gld mice are unable to express a functional ligand for Fas , 1994, European journal of immunology.
[53] N. Jenkins,et al. Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligand , 1994, Cell.
[54] G. Klaus,et al. Hypercross-linking surface IgM or IgD receptors on mature B cells induces apoptosis that is reversed by costimulation with IL-4 and anti-CD40. , 1994, Journal of immunology.
[55] G. Inghirami,et al. T-BAM/CD40-L on helper T lymphocytes augments lymphokine-induced B cell Ig isotype switch recombination and rescues B cells from programmed cell death. , 1994, Journal of immunology.
[56] Takashi Suda,et al. Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor family , 1993, Cell.
[57] F. Ramsdell,et al. Fas transduces activation signals in normal human T lymphocytes , 1993, The Journal of experimental medicine.
[58] I. Maclennan,et al. Suppression of apoptosis in normal and neoplastic human B lymphocytes by CD40 ligand is independent of Bcl‐2 induction , 1993, European journal of immunology.
[59] J. Mountz,et al. Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene , 1993, The Journal of experimental medicine.
[60] Jing Wu,et al. B-cell apoptosis induced by antigen receptor crosslinking is blocked by a T-cell signal through CD40 , 1993, Nature.
[61] K. Elkon,et al. The defect in Fas mRNA expression in MRL/lpr mice is associated with insertion of the retrotransposon, ETn , 1993, The Journal of experimental medicine.
[62] S. Nagata,et al. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[63] I. Stamenkovic,et al. The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co‐stimulatory activity. , 1992, The EMBO journal.
[64] N. Copeland,et al. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis , 1992, Nature.
[65] N. Chiorazzi,et al. Induction of T cell-dependent B cell differentiation by anti-CD3 monoclonal antibodies. , 1987, Journal of immunology.
[66] J. Gray,et al. Studies on human blood lymphocytes with iC3b (type 3) complement receptors. II. Characterization of subsets which regulate pokeweed mitogen-induced lymphocyte proliferation and immunoglobulin synthesis. , 1987, Clinical and experimental immunology.
[67] A. Coutinho,et al. A plaque assay for all cells secreting Ig of a given type or class , 1976, European journal of immunology.
[68] B. Nickoloff,et al. Sunlight-induced basal cell carcinoma tumor cells and ultraviolet-B-irradiated psoriatic plaques express Fas ligand (CD95L). , 1998, The Journal of clinical investigation.
[69] R. Eisenberg,et al. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. , 1991, Annual review of immunology.